NEU-1953
Code | Size | Price |
---|
TAR-T33651-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T33651-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
NEU-1953 is a potential candidate for sleeping sickness.
CAS:
T33651
Molecular Weight:
400.45
Purity:
0.98
SMILES:
CN(CC1)CCN1C(N=C2)=NC=C2C3=NC=C4C(N=CC=C4NC5=NC=CN=C5)=N3
References
Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development Kelly A. Bachovchin, Amrita Sharma, Seema Bag, Dana M. Klug, Katherine M. Schneider, Baljinder Singh, Hitesh B. Jalani, Melissa J. Buskes, Naimee Mehta, Scott Tanghe, Jeremiah D. Momper, Richard J. Sciotti, Ana Rodriguez, Kojo Mensa-Wilmot, Michael P. Pollastri, and Lori Ferrins Publication Date (Web): December 19, 2018 (Article) doi: 10.1021/acs.jmedchem.8b01365